CD8A and cancer: This is in line with a study using weakly immunogenic lymphoma model, reporting strong increase in CD8+ T cell infiltration into intracranial tumors following concurrent subcutaneous injection of cancer cells, leading to prolonged survival (Thomas et al., 2008).